
Proceedings Paper • Open Access
Cancer nanotechnology: a new commercialization pipeline for diagnostics, imaging agents, and therapies
Paper Abstract
Nanotechnology - the science and engineering of manipulating matter at the molecular scale to create
devices with novel chemical, physical and biological properties - has the potential to radically change
oncology. Research sponsored by the NCI Alliance for Nanotechnology in Cancer has led to the
development of nanomaterials as platforms of increasing complexity and devices of superior sensitivity,
speed and multiplexing capability. Input from clinicians has guided researchers in the design of
technologies to address specific needs in the areas of cancer therapy and therapeutic monitoring, in vivo imaging, and in vitro diagnostics. The promising output from the Alliance has led to many new companies
being founded to commercialize their nanomedical product line. Furthermore, several of these technologies,
which are discussed in this paper, have advanced to clinically testing.
Paper Details
Date Published: 13 May 2011
PDF: 11 pages
Proc. SPIE 8031, Micro- and Nanotechnology Sensors, Systems, and Applications III, 80311S (13 May 2011); doi: 10.1117/12.884607
Published in SPIE Proceedings Vol. 8031:
Micro- and Nanotechnology Sensors, Systems, and Applications III
Thomas George; M. Saif Islam; Achyut K. Dutta, Editor(s)
PDF: 11 pages
Proc. SPIE 8031, Micro- and Nanotechnology Sensors, Systems, and Applications III, 80311S (13 May 2011); doi: 10.1117/12.884607
Show Author Affiliations
Krzysztof Ptak, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
Dorothy Farrell, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
George Hinkal, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
National Institutes of Health (United States)
Dorothy Farrell, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
George Hinkal, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
Nicholas J. Panaro, SAIC-Frederick, Inc. (United States)
National Cancer Institute at Frederick (United States)
Sara Hook, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
Piotr Grodzinski, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
National Cancer Institute at Frederick (United States)
Sara Hook, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
Piotr Grodzinski, NCI Ctr. for Strategic Scientific Initiatives (United States)
National Institutes of Health (United States)
Published in SPIE Proceedings Vol. 8031:
Micro- and Nanotechnology Sensors, Systems, and Applications III
Thomas George; M. Saif Islam; Achyut K. Dutta, Editor(s)
© SPIE. Terms of Use
